Health experts have warned against underestimating the risks of "indolent tumors" as China observes its 30th "National ...

Cliff Benfield Indolent Allen follows Allen, a lazy college student who brings out the worst in every social circle he nudges into. Advertisement ...

Jill Zinsmeyer came to Austin for love, but Austin didn't love her. Living in Napa Valley, Calif., before the move, Zinsmeyer ...

Blueprint boosts Ayvakit peak sales estimate to $2B as key rare disease expansion accelerates Meanwhile, Blueprint these days ...

Harvard’s endowment is currently $50.7 billion. That means that the first year, the state would extract about $1.25 billion ...

Blueprint Medicines Corporation BPMC reported first-quarter 2024 adjusted loss of $1.32 per share, narrower than the Zacks ...

Among more than 1,300 patients diagnosed with HCC, the median survival reached 37 months for those with screening-detected ...

Purpose. The pharmacology, efficacy, safety, and dosage and administration of bendamustine and its use in indolent non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL) are reviewed.

Q1 2024 Earnings Call May 2, 2024 Blueprint Medicines Corporation misses on earnings expectations. Reported EPS is $ EPS, expectations were $-1.64. Blueprint Medicines Corporation isn’t one of the 30 ...

HAMPTON ROADS, Va. — Hematologist and Oncologist Dr. Pankit Vachhani and Suki Tipp, a woman living with Indolent Systemic Mastocytosis, join Coast Live to discuss the debilitating disease ...

He acknowledges the revenue growth driven by the increased uptake of Ayvakit in the treatment of Indolent Systemic Mastocytosis (ISM) and the benefits from the recent Medicare redesign. However, he ...

This is an open-label trial in which 100 patients with rituximab-refractory indolent B-cell NHL were treated bendamustine 120 mg/m 2 on days 1 and 2 of every 21-day cycle for six to eight cycles.